Invention Grant
- Patent Title: Method for diagnosis of primary hyperaldosteronism
-
Application No.: US15789433Application Date: 2017-10-20
-
Publication No.: US10295552B2Publication Date: 2019-05-21
- Inventor: Marko Poglitsch , Cornelia Schwager , Dunja Van Oyen , Martin Leitner
- Applicant: ATTOQUANT DIAGNOSTICS GMBH
- Applicant Address: AT Vienna
- Assignee: ATTOQUANT DIAGNOSTICS GMBH
- Current Assignee: ATTOQUANT DIAGNOSTICS GMBH
- Current Assignee Address: AT Vienna
- Agency: Norton Rose Fulbright US LLP
- Priority: EP13189386 20131018; EP14152763 20140128
- Main IPC: G01N33/50
- IPC: G01N33/50 ; G01N33/74 ; A61K31/165 ; A61K31/401 ; A61K31/4178 ; G01N33/49

Abstract:
Methods and kits for the diagnosis of primary hyperaldosteronism (PHA). In particular, the present invention relates to the use of a new diagnostic parameter that is composed of the ratio between the Ang II level, in particular the steady state equilibrium Ang II level, and the aldosterone level in a biological sample, such as e.g. plasma. The ratio of the two measured parameters is used to diagnose PHA in patients and has clear advantages over currently used diagnostic methods.
Public/Granted literature
- US20180164330A1 METHOD FOR DIAGNOSIS OF PRIMARY HYPERALDOSTERONISM Public/Granted day:2018-06-14
Information query
IPC分类: